Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model.

Ranganathan S, Doucet M, Grassel CL, Delaine-Elias B, Zachos NC, Barry EM.

Infect Immun. 2019 Mar 25;87(4). pii: e00740-18. doi: 10.1128/IAI.00740-18. Print 2019 Apr.

2.

The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.

Faherty CS, Wu T, Morris CR, Grassel CL, Rasko DA, Harper JM, Shea-Donohue T, Fasano A, Barry EM.

Gut Microbes. 2016 Nov;7(6):486-502. Epub 2016 Sep 22.

3.

Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

DeLaine BC, Wu T, Grassel CL, Shimanovich A, Pasetti MF, Levine MM, Barry EM.

Pathog Dis. 2016 Jul;74(5). pii: ftw034. doi: 10.1093/femspd/ftw034. Epub 2016 Apr 21.

4.

Characterization of intracellular growth regulator icgR by utilizing transcriptomics to identify mediators of pathogenesis in Shigella flexneri.

Morris CR, Grassel CL, Redman JC, Sahl JW, Barry EM, Rasko DA.

Infect Immun. 2013 Sep;81(9):3068-76. doi: 10.1128/IAI.00537-13. Epub 2013 Jun 10.

Supplemental Content

Loading ...
Support Center